References
- Meyer KC, Raghu G. Patient evaluation. In: Baughman RP, du Bois RM, editors. Interstitial lung disease: a practical approach. 2nd edition. Springer; NY, USA: 2011. p. 3-16
- Meyer KC. Interstitial lung disease in the elderly: pathogenesis, diagnosis and management. Sarcoidosis Vasc Diffuse Lung Dis 2011;28:3-17
- Kim R, Meyer KC. Therapies of interstitial lung disease – past, present, and future. Therapeutic Advances Respir Dis 2008;2:319-38
- ATS/ERS. InternationalMultidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002;165:277-304
- Swigris JJ, Brown KK, Flaherty KR. The idiopathic interstitial pneumonias and connective tissue disease-associated interstitial lung disease. Curr Rheum Rev 2010;6:91-8
- Raghu G, Collard HR, Egan JJ, ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183(6):788-824
- Idiopathic Pulmonary Fibrosis Clinical Research Network. Raghu G, Anstrom KJ, King TE Jr, et al. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 2012;366(21):1968-77
- American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161:646-64
- Baughman RP, Meyer KC, Nathanson I, et al. Executive summary: monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: american College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012;142(5):1284-8
- Meyer KC, Bierach J. Immunosuppressive therapy for autoimmune lung diseases. Immunol Allergy Clin North Am 2012;32(4):633-69
- Fischer A, Brown KK, Du Bois RM, et al. Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease. J Rheumatol 2013;40:640-6
- Duncan SR. The role of adaptive immunity in idiopathic pulmonary fibrosis: hiding in plain sight. In: Meyer KC, Nathan SD, editors. Idiopathic pulmonary fibrosis: a comprehensive clinical guide. Springer; NY, USA: 2013. p. 123-59
- Vittal R, Mickler EA, Fisher AJ, et al. Type V collagen induced tolerance suppresses collagen deposition, TGF-β and associated transcripts in pulmonary fibrosis. PLoS One 2013;8(10):e76451
- Sandbo N. Mechanisms of fibrosis in IPF. In: Meyer KC, Nathan SD, editors. Idiopathic pulmonary fibrosis: a comprehensive clinical guide. Springer; NY, USA: 2013. p. 161-205